
Analgesics in Switzerland
Description
Analgesics in Switzerland continues to register a positive value growth performance in Switzerland during 2025, elevated by a strong cold and flu season. The majority of Swiss consumers self-medicate when treating minor ailments such as headaches, occasional muscle aches or even minor injuries. Swiss consumers opt for OTC treatments in order to save time and money. The large variety of analgesics available without any prescription (at various dosages, in different formats, brands and generics...
Euromonitor International's Analgesics in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International's Analgesics in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
28 Pages
- Analgesics in Switzerland
- Euromonitor International
- September 2025
- List Of Contents And Tables
- ANALGESICS IN SWITZERLAND
- KEY DATA FINDINGS
- 2025 DEVELOPMENTS
- Steady pace of growth as consumers self-medicate with analgesics to treat everyday ailments
- Verfora AG takes the top spot with familiar local brands
- Pharmacies is dominant channel for analgesics
- PROSPECTS AND OPPORTUNITIES
- Ageing population and modern lifestyles to maintain low growth rates
- OTC switches offer some additional growth opportunities
- Healthier lifestyles threaten to reduce demand in the upcoming years
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2020-2025
- Table 2 Sales of Analgesics by Category: % Value Growth 2020-2025
- Table 3 NBO Company Shares of Analgesics: % Value 2021-2025
- Table 4 LBN Brand Shares of Analgesics: % Value 2022-2025
- Table 5 Forecast Sales of Analgesics by Category: Value 2025-2030
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030
- CONSUMER HEALTH IN SWITZERLAND
- EXECUTIVE SUMMARY
- Consumer Health in 2025: The big picture
- Key trends in 2025
- Competitive landscape
- Channel developments
- What next for Consumer Health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
- Table 8 Life Expectancy at Birth 2020-2025
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2020-2025
- Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025
- Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025
- Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025
- Table 14 Distribution of Consumer Health by Format: % Value 2020-2025
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2025
- Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2024-2025
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.